Clinical Trials Directory

Trials / Completed

CompletedNCT01229059

Free Fatty Acid Induced Insulin Resistance

Assessment of the Time Course of Lipid Induced Insulin Resistance

Status
Completed
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
German Diabetes Center · Academic / Other
Sex
All
Age
20 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study aims to explore time-dependent effects of lipid infusion an intramyocellular lipid metabolites and the induction of impaired insulin signaling.

Detailed description

Increased availability of free fatty acids impairs glucose disposal in young healthy humans. Patients with type 2 diabetes have reduced whole body glucose disposal, increased ectopic lipid deposition in skeletal muscle and the liver and impaired mitochondrial function. Recent studies suggest that lipid metabolites such as diacylglycerol (DAG), ceramides and long-chain acyl-coA represent the active mediators inducing insulin resistance. Possible targets are DAG-sensitive Proteinkinase C (PKC θ, PKC ε) which inhibit the insulin signaling cascade and ceramides which interfere with the insulin signaling cascade at Proteinkinase B/AKT. Prior studies raised controvesial evidence, thus, it is yet unclear, whether DAG or ceramides are the primary agents inducig lipid-induced insulin resistance. Therefore, the current study aims to explore the time course of the appearance of intramyocellular lipid compunds during lipid infusion in parallel assessing markers of impaired insulin action.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLipovenös lipid infusionLipid enriched infusions will be applied for 2-6 hours.

Timeline

Start date
2010-03-01
Primary completion
2019-11-01
Completion
2019-11-01
First posted
2010-10-27
Last updated
2023-08-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01229059. Inclusion in this directory is not an endorsement.